Khaksar S - Search Results

1

Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?

Langley S, Uribe J, Uribe-Lewis S, Mehta S, Mikropoulos C, Perna C, Otter S, Horton A, Cunningham M, Higgins D, Langley S, Deering C, Khaksar S. Langley S, et al. Among authors: khaksar s. Brachytherapy. 2022 Nov-Dec;21(6):870-876. doi: 10.1016/j.brachy.2022.08.013. Epub 2022 Oct 4. Brachytherapy. 2022. PMID: 36207244

2

Fertility after prostate brachytherapy.

Khaksar SJ, Laing RW, Langley SE. Khaksar SJ, et al. BJU Int. 2005 Oct;96(6):915. doi: 10.1111/j.1464-410X.2005.05841_1.x. BJU Int. 2005. PMID: 16153230 Review. No abstract available.

3

Interstitial low dose rate brachytherapy for prostate cancer--a focus on intermediate- and high-risk disease.

Khaksar SJ, Langley SE, Lovell D, Laing RW. Khaksar SJ, et al. Clin Oncol (R Coll Radiol). 2006 Sep;18(7):513-8. doi: 10.1016/j.clon.2006.05.005. Clin Oncol (R Coll Radiol). 2006. PMID: 16969980

4

Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy.

Khaksar SJ, Laing RW, Henderson A, Sooriakumaran P, Lovell D, Langley SE. Khaksar SJ, et al. BJU Int. 2006 Dec;98(6):1210-5. doi: 10.1111/j.1464-410X.2006.06520.x. Epub 2006 Oct 11. BJU Int. 2006. PMID: 17034501

5

Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.

Nobes JP, Wells IG, Khaksar SJ, Money-Kyrle JF, Laing RW, Langley SE. Nobes JP, et al. Among authors: khaksar sj. Prostate Cancer Prostatic Dis. 2009;12(1):61-6. doi: 10.1038/pcan.2008.17. Epub 2008 Apr 22. Prostate Cancer Prostatic Dis. 2009. PMID: 18427571 Clinical Trial.

6

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.

Nobes JP, Khaksar SJ, Hawkins MA, Cunningham MJ, Langley SE, Laing RW. Nobes JP, et al. Radiother Oncol. 2008 Jul;88(1):121-6. doi: 10.1016/j.radonc.2008.04.012. Epub 2008 May 20. Radiother Oncol. 2008. PMID: 18499289

7

Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer.

Langley SEM, Soares R, Uribe J, Uribe-Lewis S, Money-Kyrle J, Perna C, Khaksar S, Laing R. Langley SEM, et al. Among authors: khaksar s. BJU Int. 2018 Jan;121(1):38-45. doi: 10.1111/bju.13946. Epub 2017 Aug 2. BJU Int. 2018. PMID: 28670842

8

Comparative Analysis of Clinical Outcomes and Procedural Costs between the Conventional Two-stage Technique and 4D Brachytherapy for Early Prostate Cancer.

Langley SEM, Uribe J, Uribe-Lewis S, Money-Kyrle J, Perna C, Khaksar S, Soares R, Laing R. Langley SEM, et al. Among authors: khaksar s. Clin Oncol (R Coll Radiol). 2018 Jan;30(1):57-64. doi: 10.1016/j.clon.2017.09.006. Epub 2017 Oct 18. Clin Oncol (R Coll Radiol). 2018. PMID: 29054374

9

Low-dose-rate brachytherapy for the treatment of localised prostate cancer in men with a high risk of disease relapse.

Laing R, Uribe J, Uribe-Lewis S, Money-Kyrle J, Perna C, Chintzoglou S, Khaksar S, Langley SEM. Laing R, et al. Among authors: khaksar s. BJU Int. 2018 Oct;122(4):610-617. doi: 10.1111/bju.14223. Epub 2018 May 8. BJU Int. 2018. PMID: 29607601

10

Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancer.

Langley S, Uribe J, Uribe-Lewis S, Franklin A, Perna C, Horton A, Cunningham M, Higgins D, Deering C, Khaksar S, Laing R. Langley S, et al. Among authors: khaksar s. BJU Int. 2020 Mar;125(3):383-390. doi: 10.1111/bju.14948. Epub 2019 Dec 23. BJU Int. 2020. PMID: 31705700 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters